Research
Adherence
Continuous Glucose Monitoring (CGM) and automated insulin delivery systems significantly improve glycemic control accuracy, reduce hypoglycemia risk, and enhance treatment adherence in patients with Type 1 Diabetes and insulin-treated Type 2 Diabetes.
If you use insulin, ask your doctor about Continuous Glucose Monitoring (CGM). It gives you real-time data on your blood sugar, helping you avoid dangerous lows and highs, and makes managing your diabetes much easier and safer.
GoodSupportsHIGH confidence
Innovations in diabetes management devices, including continuous glucose monitoring systems, smart insulin pens, and automated insulin delivery systems, have improved glucose control accuracy and enhanced treatment adherence.
Why this rating
Supported by clinical guidelines and studies showing improved outcomes with CGM.
Source
당뇨병 치료의 진화: 관해를 향해가는 혁신적 약물치료와 첨단 관리기기의 결합
Jong Han Choi et al. · Public Health Weekly Report · 2024
narrative_review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →